Serum Heart Type Fatty Acid Binding Protein Levels in Primary Hyperparathyroidism

Creative Commons License

Ucan B., ŞAHİN M., Ozbek M., Caliskan M., Kizilgul M., Ozturk G., ...More

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.22, no.1, pp.1-6, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.25179/tjem.2017-57329
  • Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-6
  • Keywords: Hyperparathyroidism, H-FABP, cardiovascular risk, HEALTH-CARE PROFESSIONALS, PARATHYROID-HORMONE, BLOOD-PRESSURE, PULMONARY-EMBOLISM, RISK-FACTORS, FOLLOW-UP, DISEASE, ASSOCIATION, POPULATION, ABNORMALITIES
  • Ankara University Affiliated: Yes

Abstract

Purpose: Recent studies indicate that plasma heart-type fatty acid binding-protein (H-FABP) concentration can be used as an early biochemical marker for macrovascular diseases. Patients with primary hyperparathyroidism (PHT) reportedly display an increase in cardiovascular (CV) risk factors. Our aim was to evaluate plasma H-FABP concentration in these subjects with primary hyperparathyroidism, by comparing them with healthy controls.